Comparison

BMS-986202

Item no. DCC-DC70265-100mg
Manufacturer DCChemicals
CASRN 1771691-34-9
Amount 100 mg
Category
Type Inhibitors
Applications other, IV
Specific against other
Smiles FC1C([H])=NC(C2C([H])=C([H])C([H])=C(C=2OC([H])([H])[H])N([H])C2C(C(N([H])C([2H])([2H])[2H])=O)=C([H])N=C(C=2[H])N([H])C(C2([H])C([H])([H])C2([H])[H])=O)=NC=1[H]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Manufacturer - Applications
BMS-986202 (BMS 986202) is potent, selective Tyk2 inhibitor that binds to Tyk2 JH2 domain with IC50 of 0.19 nM, Ki of 0.02 nM, >10, 000-fold over 273 kinases and pseudokinases;
BMS-986202 demonstrated cellular activity (IL-23 IC50=12 nM) in IL-23 stimulated reporter assay (in Kit225 T cells).
BMS-986202 also binds Jak1 JH2 with an IC50 of 7.8 nM, but this enzymatic binding did not lead to any functional activities, as BMS-986202 displayed an activity (IC50) of greater than 12.5 μM in the IL-2 stimulated Jak1/3-dependent cellular assay.
BMS-986202 showed in vivo efficacy in mouse models of IL-23-driven acanthosis, anti-CD40-induced colitis, and spontaneous lupus.
Molecular Weight
439, 4574

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close